Tumour Hypoxia: Impact on Biology, Prognosis and Treatment of Solid Malignant Tumours
Klinik für Radioonkologie, Universität Tübingen, Germany. Onkologie
(Impact Factor: 0.86).
03/2004; 27(1):83-90. DOI: 10.1159/000075611
Tumour hypoxia is a major constraint for radiotherapy and many types of chemotherapy. A variety of different pathogenetic mechanisms contribute to the development of hypoxia in solid tumours. Hypoxia is associated with unfavourable prognosis, regardless of the treatment modality applied. Two different effects have been considered to explain the deleterious effects of hypoxia on the outcome of tumour patients. The first aspect encompasses the direct interference of hypoxia with antineoplastic treatment modalities. The efficacy of ionizing radiation, but also of a variety of cytotoxic drugs and cytokines rely directly on adequate oxygen tensions. The second aspect concerns the effects of hypoxia on the biology of tumour and stromal cells. Hypoxia is related to malignant progression, increased invasion, angiogenesis and an increased risk of metastasis formation. Possibly, hypoxia is furthermore a stressor which selects cells with increased resistance to apoptosis and thereby indirectly contributes to treatment resistance. This article reviews in brief the specific pathophysiology of tumour oxygenation and its implications for prognosis, tumour treatment and biology.
Available from: Nathaniel Melling
- "Several reports have described a close relationship between genetic stability of the tumor and the selective pressure of the tumor microenvironment . Many biomarkers predicting the response to chemotherapy are suggested to be linked to pathways of cell survival that are activated as adaptive response mechanisms in stressing microenvironments such as poor nutrient supply or low oxygen levels . One candidate that is suggested to play an important role in cancer cell survival is class III β-tubulin (TUBB3) "
Cancer Treatment Communications 12/2015; 4:96-102. DOI:10.1016/j.ctrc.2015.06.004
Available from: Aleksandra M Kubiak
- "In addition, some solid tumours are found to have necrotic (dead) cores, a direct effect of long-standing tissue hypoxia  . Tumour hypoxia has been demonstrated to reduce the efficacy of many standard cytotoxic drugs used in the treatment of cancer . This is due to ineffective penetration of the drug into the hypoxic mass of the tumour, due to poor vascularisation . "
[Show abstract] [Hide abstract]
ABSTRACT: Despite substantial investment in prevention, treatment and aftercare, cancer remains a leading cause of death worldwide. More effective and accessible therapies are required. A potential solution is the use of endospore forming Clostridium species, either on their own, or as a tumour delivery vehicle for anti-cancer drugs. This is because intravenously injected spores of these obligate anaerobes can exclusively germinate in the hypoxic/necrotic regions present in solid tumours and nowhere else in the body. Research aimed at exploiting this unique phenomenon in anti-tumour strategies has been ongoing since the early part of the 20th century. Only in the last decade, however, has there been significant progress in the development and refinement of strategies based on spore-mediated tumour colonisation using a range of clostridial species. Much of this progress has been due to advances in genomics and our ability to modify strains using more sophisticated gene tools.
Research in Microbiology 01/2015; 166(4). DOI:10.1016/j.resmic.2014.12.006 · 2.71 Impact Factor
Available from: Asta Juzeniene
- "With few exceptions, solid tumors have regions with little or no oxygen   . This is due to poor vascularization and is called hypoxia (low oxygen tension) or anoxia (no oxygen). "
[Show abstract] [Hide abstract]
ABSTRACT: The sections in this article areIntroductionThe Role of Oxygen in Photodynamic Therapy: 1O2 GenerationDependence of the Photosensitizing Effect on O2 ConcentrationThe Oxygenation Status in Tumors and Normal TissuesPDT-Induced Reduction of Tumor OxygenationO2 Consumption (Primary Reduction)Vascular Damage (Secondary Reactions)Photosensitizer Photobleaching (Secondary Reactions)Methods to Reduce Tumor Deoxygenation During PDTLow Fluence RatesFractionated Light ExposureOther Methods
Changes of Quantum Yields Related to Photosensitizer RelocalizationChanges of Optical Penetration Caused by Changes in O2 ConcentrationConclusion
Keywords:photodynamic therapy;oxygen;photosensitization;oxygenation;tumor deoxygenation;cancer
Handbook of Biophotonics, 01/2013; , ISBN: 9783527643981
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.